Zelira Therapeutics Limited Stock: price and insider trades · Australia
Zelira Therapeutics Limited: what insiders have been doing
Insider filings for Zelira Therapeutics Limited are scarce in the ASX feed, the latest one published on 2 July 2026. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended June 2025 · cache
- 0@ A$0.400.0000% mcap100.0% of flowShareASXISIN AU000000ZLD1ASX:2924-03106942-6A1332188
1 of 1 declaration
About Zelira Therapeutics Limited
Zelira Therapeutics Limited is a company focused on developing cannabinoid-based therapies. It is listed on the Australian Securities Exchange (ASX).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
